FDA Approved: MESALAMINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings' original ANDA for Mesalamine, a generic formulation of the anti-inflammatory drug used to treat ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)